<?xml version="1.0" encoding="UTF-8"?>
<p id="Par13">An initiative that may help neuromuscular centres to reorganize patient care is the use of quality-of-life surveys sent to NMD patients to follow up on their feelings and needs and consequently modulate appropriate responses, as already assessed in immunocompromised patients [
 <xref ref-type="bibr" rid="CR15">15</xref>]. In parallel, nationwide surveys may help to quickly identify NMD patients who suffered from severe SARS-CoV-2 infection in other regions/states of the country and promptly manage possible complications—such as ventilation-associated pulmonary damage, critical-illness myopathies, and neuropathies and emerging COVID-related neurologic manifestations [
 <xref ref-type="bibr" rid="CR16">16</xref>–
 <xref ref-type="bibr" rid="CR18">18</xref>]—that were reported during the SARS-CoV-1 pandemic in 2002–2004 [
 <xref ref-type="bibr" rid="CR19">19</xref>].
</p>
